{"id":"NCT00152516","sponsor":"UCB Pharma","briefTitle":"Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures","officialTitle":"A Multi-Center, Open-Label, Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-10","primaryCompletion":"2008-06","completion":"2008-06","firstPosted":"2005-09-09","resultsPosted":"2010-01-13","lastUpdate":"2013-02-12"},"enrollment":255,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Epilepsy, Partial"],"interventions":[{"type":"DRUG","name":"levetiracetam (LEV)","otherNames":["Keppra"]}],"arms":[{"label":"Levetiracetam","type":"EXPERIMENTAL"}],"summary":"To allow pediatric patients with partial onset seizures an opportunity to receive (as follow-up to studies N01009(NCT00105040)/N01103(NCT00175890) or by direct enrollment) open-label levetiracetam treatment, continue studying cognition and behavior in children, and continue collection of safety/efficacy data.","primaryOutcome":{"measure":"Percentage Change (Reduction) of Partial (Type I) Seizure Frequency Per Week From Baseline Over Time During Treatment Period.","timeFrame":"Up-titration/Conversion Period (2-8 weeks); Maintenance Period (2-8 weeks to 40-46 weeks)","effectByArm":[{"arm":"Levetiracetam","deltaMin":51.06,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Month","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":5},"locations":{"siteCount":84,"countries":["United States","Belgium","Brazil","Canada","Czechia","France","Germany","Hungary","India","Italy","Mexico","Poland","Romania","Russia","South Africa","United Kingdom"]},"refs":{"pmids":["21095488"],"seeAlso":["http://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"]},"adverseEventsSummary":{"seriousAny":{"events":46,"n":255},"commonTop":["Pyrexia","Upper respiratory tract infection","Vomiting","Nasopharyngitis","Diarrhoea"]}}